PlumX Metrics
Embed PlumX Metrics

Optimal Blood Pressure Control Target for Older Patients with Hypertension: A Systematic Review and Meta-Analysis

Cardiovascular Innovations and Applications, ISSN: 2009-8782, Vol: 7, Issue: 1
2023
  • 3
    Citations
  • 0
    Usage
  • 11
    Captures
  • 4
    Mentions
  • 34
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    3
  • Captures
    11
  • Mentions
    4
    • News Mentions
      4
      • News
        4
  • Social Media
    34
    • Shares, Likes & Comments
      34
      • Facebook
        34

Most Recent News

Report Summarizes Hypertension Study Findings from Second Affiliated Hospital of Chongqing Medical University (Optimal Blood Pressure Control Target for Older Patients with Hypertension: A Systematic Review and Meta-Analysis)

2023 APR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Hospital & Nursing Home Daily -- A new study on hypertension is now

Review Description

Objective: This study evaluated the optimal systolic blood pressure (SBP) target for older patients with hypertension. Method: A Bayesian network meta-analysis was conducted. The risk of bias of the included studies was assessed by using a modified version of the Cochrane risk of bias. The trial outcomes comprised the following clinical events: major adverse cardiovascular events (MACE), cardiovascular mortality, all-cause mortality, myocardial infarction, heart failure and stroke. Results: A total of six trials were included. We reclassified all treatment therapies into three conditions according to the final achieved SBP after intervention (<130 mmHg, 130–139 mmHg and ≥140 mmHg). Our results demonstrated that anti-hypertensive treatment with an SBP target <130 mmHg, compared with treatment with an SBP target ≥140 mmHg, significantly decreased the incidence of MACE (OR 0.43, 95%CI 0.19–0.76), but no statistical difference was found in other comparisons. Although the results showed a trend toward more intensive anti-hypertension therapy having better effects on preventing cardiovascular mortality, all-cause mortality, myocardial infarction, heart failure, and stroke, no significant differences were found among groups. Conclusions: Our meta-analysis suggested that SBP <130 mmHg might be the optimal BP control target for patients ≥60 years of age; however, further evidence is required to support our findings.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know